Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Louisville, Kentucky 40202


Purpose:

The purpose of this study is to determine how berries affect cancer tumors in patients with non-small cell lung cancer.


Study summary:

In the United States, more people (161,840 per year) die of lung cancers than of prostate cancer, breast cancer and colon cancer combined. Presently, there are over 43 million current smokers and over 47 million ex-smokers living in the US. Due to the lag time between smoking and the development of cancer, there are significant numbers of ex-smokers and current smokers who may develop lung cancer compared to never smokers. Recent studies in animals have shown that berries, given as a dietary supplement, are highly effective against certain types of cancers. In a study involving mice with lung tumors, mice that had consumed a mixture of berries developed fewer tumors and had less tumor growth than mice that did not consume berries. The berries used in this study will consist of blueberries, black raspberries, or a mixture of both.


Criteria:

Inclusion Criteria (lung cancer survivors): - men treated for lung cancer, women treated for lung cancer and with no child-bearing potential (hysterectomy, tubal ligation, post-menopausal women) Exclusion Criteria (lung cancer survivors): - women who are on hormone replacement therapy - women who are pregnant, or planning for pregnancy - history of lung transplant - prison inmate - inability to take oral medication or food - known or suspected allergy to berries or berry products - HIV patients Inclusion Criteria (volunteers): - adult men, adult women with no child bearing potential (hysterectomy, tubal ligation, post-menopausal women) Exclusion Criteria (volunteers): - women who are on hormone replacement therapy - women who are pregnant, or planning for pregnancy - history of lung transplant - prison inmate - inability to take oral medication or food - known or suspected allergy to berries or berry products - HIV patients


NCT ID:

NCT00681512


Primary Contact:

Principal Investigator
Ramesh Gupta, PhD
James Graham Brown Cancer Center


Backup Contact:

N/A


Location Contact:

Louisville, Kentucky 40202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.